These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 8549386

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Cefixime in the treatment of lower respiratory tract infections in patients with chronic bronchitis].
    Marcos Sánchez F, Reinoso Cobo D, García Camba L, Celdrán Gil JL.
    An Med Interna; 1995 Mar; 12(3):150-1. PubMed ID: 7795125
    [No Abstract] [Full Text] [Related]

  • 4. Efficacy of oral ciprofloxacin vs. clarithromycin for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group.
    Chodosh S, Schreurs A, Siami G, Barkman HW, Anzueto A, Shan M, Moesker H, Stack T, Kowalsky S.
    Clin Infect Dis; 1998 Oct; 27(4):730-8. PubMed ID: 9798025
    [Abstract] [Full Text] [Related]

  • 5. Randomized, double-blind study of ciprofloxacin and cefuroxime axetil for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group.
    Chodosh S, McCarty J, Farkas S, Drehobl M, Tosiello R, Shan M, Aneiro L, Kowalsky S.
    Clin Infect Dis; 1998 Oct; 27(4):722-9. PubMed ID: 9798024
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and tolerability of twice-daily ciprofloxacin 750 mg in the treatment of patients with acute exacerbations of chronic bronchitis and pneumonia.
    Pryka R, Kowalsky S, Haverstock D.
    Clin Ther; 1998 Oct; 20(1):141-55. PubMed ID: 9522111
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Cefixime therapy in sinusitis].
    Jorde W, Schata M.
    Infection; 1990 Oct; 18 Suppl 3():S129-31. PubMed ID: 2079372
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Efficacy and tolerability of cefixime in lower respiratory tract infections in adults. French multicentric study].
    Modai J.
    Presse Med; 1989 Oct 11; 18(32):1605-7. PubMed ID: 2530543
    [Abstract] [Full Text] [Related]

  • 15. [Treatment results using cefixime for bacterial respiratory tract infections].
    Leonhardt L.
    Infection; 1990 Oct 11; 18 Suppl 3():S115-8. PubMed ID: 2079368
    [Abstract] [Full Text] [Related]

  • 16. [Clinical efficacy of cefixime (results of multicenter trials)].
    Sereda EV, Gusel' VA, Feshchenko IuI, Ustinovich AK, Zubovich VK, Trofimov VI, Nedostup AV, Ovchinnikov IuM, Pluzhnikov MS, Darenkov AF.
    Antibiot Khimioter; 1993 Jun 11; 38(6):45-50. PubMed ID: 8166566
    [Abstract] [Full Text] [Related]

  • 17. Quinolone antimicrobial agents in acute exacerbations of chronic bronchitis.
    Maesen FP, Davies BI, Teengs JP, Baur C.
    Eur J Respir Dis Suppl; 1986 Jun 11; 146():585-90. PubMed ID: 3465584
    [No Abstract] [Full Text] [Related]

  • 18. Oral treatment of gonorrhea and chlamydia.
    Loughlin KA, Bakst CM, Rybak MJ.
    Ann Pharmacother; 1994 May 11; 28(5):600-2. PubMed ID: 8068998
    [No Abstract] [Full Text] [Related]

  • 19. [Effectiveness and tolerance of cefixime in bacterial infections in the ENT area].
    Theopold M, Benner U, Bauernfeind A.
    Infection; 1990 May 11; 18 Suppl 3():S122-4. PubMed ID: 2079370
    [Abstract] [Full Text] [Related]

  • 20. Clinical and economic considerations in the treatment of acute exacerbations of chronic bronchitis.
    Destache CJ, Dewan N, O'Donohue WJ, Campbell JC, Angelillo VA.
    J Antimicrob Chemother; 1999 Mar 11; 43 Suppl A():107-13. PubMed ID: 10225580
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.